Warning: The NCBI web site requires JavaScript to function. more...

PubMed

US National Library of Medicine National Institutes of Health

RSS
RSS Settings
- Search: Fibroblast Growth Factor 19
- Number of items displayed:
- Feed name:
Save search
Advanced
Help

We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

<< First< Prev

Page of 87

Next >Last >>

Results: 1 to 20 of 1725

Select item 236748491.

Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.

Chen G, Qiu H, Ke SD, Hu SM, Yu SY, Zou SQ.

World J Gastroenterol. 2013 Apr 28;19(16):2481-91. doi: 10.3748/wjg.v19.i16.2481.

PMID:: 23674849; [PubMed - in process]

Free PMC Article

Related citations

Select item 236709682.

Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.

Haluzíková D, Lacinová Z, Kaválková P, Drápalová J, Křížová J, Bártlová M, Mráz M, Petr T, Vítek L, Kasalický M, Haluzík M.

Obesity (Silver Spring). 2012 Nov 29. doi: 10.1002/oby.20208. [Epub ahead of print]

PMID:: 23670968; [PubMed - as supplied by publisher]

Related citations

Select item 236579463.

Fibroblast Growth Factor Receptor 3 is a Rational Therapeutic Target in Bladder Cancer.

Gust KM, McConkey DJ, Awrey S, Hegarty PK, Qing J, Bondaruk J, Ashkenazi A, Czerniak B, Dinney CP, Black PC.

Mol Cancer Ther. 2013 May 8. [Epub ahead of print]

PMID:: 23657946; [PubMed - as supplied by publisher]

Related citations

Select item 236472554.

Wound dressing composed of hyaluronic acid and collagen containing EGF or bFGF: comparative culture study.

Yu A, Niiyama H, Kondo S, Yamamoto A, Suzuki R, Kuroyanagi Y.

J Biomater Sci Polym Ed. 2013 Jun;24(8):1015-26. doi: 10.1080/09205063.2012.731375. Epub 2012 Nov 26.

PMID:: 23647255; [PubMed - in process]

Related citations

Select item 236362375.

Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.

Tanaka T, Ngwa JS, van Rooij FJ, Zillikens MC, Wojczynski MK, Frazier-Wood AC, Houston DK, Kanoni S, Lemaitre RN, Luan J, Mikkilä V, Renstrom F, Sonestedt E, Zhao JH, Chu AY, Qi L, Chasman DI, de Oliveira Otto MC, Dhurandhar EJ, Feitosa MF, Johansson I, Khaw KT, Lohman KK, Manichaikul A, McKeown NM, Mozaffarian D, Singleton A, Stirrups K, Viikari J, Ye Z, Bandinelli S, Barroso I, Deloukas P, Forouhi NG, Hofman A, Liu Y, Lyytikäinen LP, North KE, Dimitriou M, Hallmans G, Kähönen M, Langenberg C, Ordovas JM, Uitterlinden AG, Hu FB, Kalafati IP, Raitakari O, Franco OH, Johnson A, Emilsson V, Schrack JA, Semba RD, Siscovick DS, Arnett DK, Borecki IB, Franks PW, Kritchevsky SB, Lehtimäki T, Loos RJ, Orho-Melander M, Rotter JI, Wareham NJ, Witteman JC, Ferrucci L, Dedoussis G, Cupples LA, Nettleton JA.

Am J Clin Nutr. 2013 Jun;97(6):1395-1402. Epub 2013 May 1.

PMID:: 23636237; [PubMed - as supplied by publisher]

Free Article

Related citations

Select item 236286196.

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels.

Fang Q, Li H, Song Q, Yang W, Hou X, Ma X, Lu J, Xu A, Jia W.

Diabetes Care. 2013 Apr 29. [Epub ahead of print]

PMID:: 23628619; [PubMed - as supplied by publisher]

Related citations

Select item 236077017.

Involvement of fibroblast growth factor in the restoration of arterial baroreflex by dietary restriction.

Zang P, Dong J, Song XR, Zhang LL, Liu AJ.

CNS Neurosci Ther. 2013 May;19(5):367-8. doi: 10.1111/cns.12097. No abstract available.

PMID:: 23607701; [PubMed - in process]

Related citations

Select item 236032738.

Position effect on FGF13 associated with X-linked congenital generalized hypertrichosis.

Destefano GM, Fantauzzo KA, Petukhova L, Kurban M, Tadin-Strapps M, Levy B, Warburton D, Cirulli ET, Han Y, Sun X, Shen Y, Shirazi M, Jobanputra V, Cepeda-Valdes R, Cesar Salas-Alanis J, Christiano AM.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7790-5. doi: 10.1073/pnas.1216412110. Epub 2013 Apr 19.

PMID:: 23603273; [PubMed - in process]

Related citations

Select item 235929269.

Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields.

Wang J, Cui J, Zhu H.

Mol Vis. 2013 Apr 12;19:885-93. Print 2013.

PMID:: 23592926; [PubMed - in process]

Free PMC Article

Related citations

Select item 2359129110.

Hyponatremia, Mineral Metabolism, and Mortality in Incident Maintenance Hemodialysis Patients: A Cohort Study.

Nigwekar SU, Wenger J, Thadhani R, Bhan I.

Am J Kidney Dis. 2013 Apr 13. doi:pii: S0272-6386(13)00587-8. 10.1053/j.ajkd.2013.02.367. [Epub ahead of print]

PMID:: 23591291; [PubMed - as supplied by publisher]

Related citations

Select item 2358534611.

Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1 year double-blind RCT in postmenopausal women.

Macdonald HM, Wood AD, Aucott LS, Black AJ, Fraser WD, Mavroeidi A, Reid DM, Secombes KR, Simpson WG, Thies F.

J Bone Miner Res. 2013 Apr 13. doi: 10.1002/jbmr.1959. [Epub ahead of print]

PMID:: 23585346; [PubMed - as supplied by publisher]

Related citations

Select item 2358271712.

Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression.

Sun DP, Yeh CH, So E, Wang LY, Wei TS, Chang MS, Hsing CH.

Cytokine. 2013 Jun;62(3):360-8. doi: 10.1016/j.cyto.2013.03.017. Epub 2013 Apr 10.

PMID:: 23582717; [PubMed - in process]

Related citations

Select item 2357476013.

Bile Acid malabsorption deactivates pregnane x receptor in patients with Crohn's disease.

Iwamoto J, Saito Y, Honda A, Miyazaki T, Ikegami T, Matsuzaki Y.

Inflamm Bowel Dis. 2013 May;19(6):1278-84. doi: 10.1097/MIB.0b013e318281f423.

PMID:: 23574760; [PubMed - in process]

Related citations

Select item 2356920814.

Repression of Myoblast Proliferation and Fibroblast Growth Factor Receptor 1 Promoter Activity by KLF10 Protein.

Parakati R, Dimario JX.

J Biol Chem. 2013 May 10;288(19):13876-84. doi: 10.1074/jbc.M113.457648. Epub 2013 Apr 8.

PMID:: 23569208; [PubMed - in process]

Related citations

Select item 2356544315.

Hypophosphatemic rickets: A case of recurrent pathological fractures.

Baidya A, Chowdhury S, Mukhopadhyay S, Ghosh S.

Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S402-4. doi: 10.4103/2230-8210.104108.

PMID:: 23565443; [PubMed]

Free PMC Article

Related citations

Select item 2354110816.

Tendon healing and anti-adhesion properties of electrospun fibrous membranes containing bFGF loaded nanoparticles.

Liu S, Qin M, Hu C, Wu F, Cui W, Jin T, Fan C.

Biomaterials. 2013 Jun;34(19):4690-701. doi: 10.1016/j.biomaterials.2013.03.026. Epub 2013 Mar 26.

PMID:: 23541108; [PubMed - in process]

Related citations

Select item 2354026017.

Circulating α-Klotho Levels in CKD and Relationship to Progression.

Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.

Am J Kidney Dis. 2013 Jun;61(6):899-909. doi: 10.1053/j.ajkd.2013.01.024. Epub 2013 Mar 27.

PMID:: 23540260; [PubMed - in process]

Related citations

Select item 2353601118.

Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer.

Harding TC, Long L, Palencia S, Zhang H, Sadra A, Hestir K, Patil N, Levin A, Hsu AW, Charych D, Brennan T, Zanghi J, Halenbeck R, Marshall SA, Qin M, Doberstein SK, Hollenbaugh D, Kavanaugh WM, Williams LT, Baker KP.

Sci Transl Med. 2013 Mar 27;5(178):178ra39. doi: 10.1126/scitranslmed.3005414.

PMID:: 23536011; [PubMed - in process]

Related citations

Select item 2353284819.

Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity.

Salzmann S, Seher A, Trebing J, Weisenberger D, Rosenthal A, Siegmund D, Wajant H.

J Biol Chem. 2013 May 10;288(19):13455-66. doi: 10.1074/jbc.M112.435917. Epub 2013 Mar 26.

PMID:: 23532848; [PubMed - in process]

Related citations

Select item 2351868320.

Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids.

Zhang JH, Nolan JD, Kennie SL, Johnston IM, Dew T, Dixon PH, Williamson C, Walters JR.

Am J Physiol Gastrointest Liver Physiol. 2013 May;304(10):G940-8. doi: 10.1152/ajpgi.00398.2012. Epub 2013 Mar 21.

PMID:: 23518683; [PubMed - in process]

Related citations

<< First< Prev

Page of 87

Next >Last >>

Supplemental Content

Filters: Manage Filters

Results by year

Download CSV

PMC Images search for Fibroblast Growth Factor 19

Figure 3

Receiver-operating characteristic analysis for fibroblast growth factor 19 (FGF19) detection of C4 >60 ng/ml. True-positive and false-positive rate data are shown for FGF19 in 258 patients (square symbols). The line of no discrimination is also shown.

Fibroblast Growth Factor 19 and 7?-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea

Clin Transl Gastroenterol. 2012 July;3(7):e18.
Figure 2

Inverse correlation between C4 and fibroblast growth factor 19 (FGF19). Fasting C4 and FGF19 values are shown for individual patients. Open symbols are patients in group 1 with C4 ≤28 ng/ml. Solid symbols are patients in group 2 with C4 >28 ng/ml.

Fibroblast Growth Factor 19 and 7?-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea

Clin Transl Gastroenterol. 2012 July;3(7):e18.
Figure 1

Fasting C4 and fibroblast growth factor 19 (FGF19) levels within each group of patients investigated for chronic diarrhea. C4 is shown on the left and FGF19 on the right. In each part of the figure, the median, 25th, and 75th quartiles (boxes) and the 10th and 90th percentiles (whiskers) are shown. Group 1 comprises 119 patients with C4≤28 ng/ml. Group 2 comprises 139 patients with C4>28 ng/ml.

Fibroblast Growth Factor 19 and 7?-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea

Clin Transl Gastroenterol. 2012 July;3(7):e18.
FIGURE 4Receptor activation by FGFs 19, 21, and 23

A, heparin dose response for FGFs 19, 21, and 23 measured on FGFR1c-expressing BaF3 cells. Activity increases with increasing heparin but appears to plateau at concentrations >10 μg/ml. B, FGF1 control activity used to normalize the activity of FGFs 19, 21, and 23. C, BaF3 cell mitogenic assay for c-spliced FGFRs. D, BaF3 cell mitogenic assay for b-spliced FGFRs and FGFR4Δ.

Receptor Specificity of the Fibroblast Growth Factor Family

J Biol Chem. 2006 June 9;281(23):15694-15700.

See more (70)...

Titles with your search terms

Role of fibroblast growth factor 19 in the control of glucose homeostasis. [Curr Opin Clin Nutr Metab Care...]
Role of fibroblast growth factor 19 in the control of glucose homeostasis.
Schaap FG. Curr Opin Clin Nutr Metab Care. 2012 Jul; 15(4):386-91.
Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. [Endocrinology. 2013]
Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats.
Ryan KK, Kohli R, Gutierrez-Aguilar R, Gaitonde SG, Woods SC, Seeley RJ. Endocrinology. 2013 Jan; 154(1):9-15. Epub 2012 Nov 26.
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. [BMC Cancer. 2012]
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
Miura S, Mitsuhashi N, Shimizu H, Kimura F, Yoshidome H, Otsuka M, Kato A, Shida T, Okamura D, Miyazaki M. BMC Cancer. 2012 Feb 6; 12:56. Epub 2012 Feb 6.

278 free full-text articles in PubMed Central

Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling. [World J Gastroenterol. 2013]
Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.
Chen G, Qiu H, Ke SD, Hu SM, Yu SY, Zou SQ. World J Gastroenterol. 2013 Apr 28; 19(16):2481-91.
Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields. [Mol Vis. 2013]
Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields.
Wang J, Cui J, Zhu H. Mol Vis. 2013; 19:885-93. Epub 2013 Apr 12.
Hypophosphatemic rickets: A case of recurrent pathological fractures. [Indian J Endocrinol Metab. 2012]
Hypophosphatemic rickets: A case of recurrent pathological fractures.
Baidya A, Chowdhury S, Mukhopadhyay S, Ghosh S. Indian J Endocrinol Metab. 2012 Dec; 16(Suppl 2):S402-4.